HOTAIR负性调控miR-638/14-3-3σ轴促进肺腺癌转移的功能及机制研究

批准号:
81602030
项目类别:
青年科学基金项目
资助金额:
17.0 万元
负责人:
王燃燃
依托单位:
学科分类:
H1805.肿瘤表观遗传
结题年份:
2019
批准年份:
2016
项目状态:
已结题
项目参与者:
李征、胡长梅、袁昭顺、贾利晴、葛小路
国基评审专家1V1指导 中标率高出同行96.8%
结合最新热点,提供专业选题建议
深度指导申报书撰写,确保创新可行
指导项目中标800+,快速提高中标率
微信扫码咨询
中文摘要
浸润型肺腺癌患者由于肿瘤的转移,其生存率明显低于原位型和微小浸润型肺腺癌。前期研究表明HOTAIR表达增高与肺腺癌患者预后差及淋巴结转移呈正相关,HOTAIR增强肺腺癌转移与侵袭能力。同时检测到14-3-3σ在肺腺癌中表达与HOTAIR呈正相关,而靶向14-3-3σ的miR-638与HOTAIR表达负相关。14-3-3σ通过调控细胞骨架动力学促进肿瘤转移。由此,我们提出科学假设:HOTAIR负性调控miR-638/14-3-3σ轴促进肺腺癌的转移。本项目首先在细胞和动物模型中探讨HOTAIR/14-3-3σ在肺腺癌转移中的功能及对细胞骨架的调控;其次验证HOTAIR通过沉默miR-638上调14-3-3σ的分子机制;最后,从大样本回顾性分析中总结HOTAIR/miR-638/14-3-3σ对于肺腺癌及转移的临床相关性和预后判断价值。
英文摘要
The survival rate of patients with invasive pulmonary adenocarcinoma is significantly lower than in in-situ and minimally invasive lung adenocarcinoma due to tumor metastasis. Our previous work showed that HOTAIR higher expression in patients with lung adenocarcinoma was positive correlation with poor prognosis and lymph node metastasis. HOTAIR could enhance the metastasis and invasion ability of lung adenocarcinoma cells. 14-3-3σ was also higher in lung adenocarcinoma with positive correlated with HOTAIR expression, and miR-638 targeted 14-3-3σ was negatively correlated with HOTAIR expression in lung adenocarcinoma. Previous reports have shown that 14-3-3σ directed cell migration and tumor invasion through regulating cytoskeletal dynamics. Based on these results, we propose that HOTAIR negatively regulates miR-638/14-3-3σ axis promoting the metastasis of lung adenocarcinoma. In this project, firstly, we should verify the roles of HOTAIR and 14-3-3σ in the metastasis of lung adenocarcinoma and mechanisms of regulation the cytoskeleton dynamics in cell and animal models. Secondly, it is studied that the molecular mechanism of HOTAIR raises the 14-3-3σ expression through silence the miR-638 in lung adenocarcinoma. Finally, HOTAIR/miR-638/14-3-3σ relations with the metastasis and prognosis of patients with lung adenocarcinoma were observed via retrospective analyses in large clinical samples.
浸润型肺腺癌患者由于肿瘤的转移,其生存率明显低于原位型和微小浸润型肺腺癌。我们重点关注的是长链非编码RNA(lncRNA)在肺腺癌转移中的作用机制。前期研究中我们发现LncRNA HOTAIR与14-3-3σ在非小细胞肺癌中均高表达,两者正相关。接着我们利用芯片检测和生信分析筛选在肺腺癌组织中有明显差异性表达的LncRNA。发现lncRNA CAR10和HCP5在肺腺癌中高表达,进一步对两者的功能及机制进行了研究,分别证明了:1)lncRNA CAR10在体外、体内促进肺癌细胞的侵袭和转移,其作用机制是通过miR-203/30/SNAL轴增加肺腺癌细胞的EMT转化;CAR10是潜在的肺腺癌诊断与预后的标志物;2)LncRNA HCP5也是促进肺腺癌细胞侵袭和转移的LncRNA之一,其在肺腺癌中的高表达受TGF-β/SMAD3的转录调控。本研究为深入认识lncRNA在肺腺癌转移过程中的作用及机制提供了新的研究思路。
期刊论文列表
专著列表
科研奖励列表
会议论文列表
专利列表
Long non-coding RNA HOX transcript antisense RNA promotes expression of 14-3-3 sigma in non-small cell lung cancer
长非编码RNA HOX转录反义RNA促进非小细胞肺癌14-3-3 sigma的表达
DOI:10.3892/etm.2017.5041
发表时间:2017
期刊:Experimental and Therapeutic Medicine
影响因子:2.7
作者:Wang Ranran;Yan Bin;Li Zheng;Jiang Yiqun;Mao Chao;Wang Xiang;Zhou Xinmin
通讯作者:Zhou Xinmin
DOI:10.3892/ijo.2019.4850
发表时间:2019
期刊:International Journal of Oncology
影响因子:--
作者:Jiang Lin;Li Zheng;Wang Ranran
通讯作者:Wang Ranran
HCP5 is a SMAD3-responsive long non-coding RNA that promotes lung adenocarcinoma metastasis via miR-203/SNAI axis
HCP5是一种SMAD3响应性长非编码RNA,通过miR-203/SNAI轴促进肺腺癌转移
DOI:10.7150/thno.31097
发表时间:2019-01-01
期刊:THERANOSTICS
影响因子:12.4
作者:Jiang, Lin;Wang, Ranran;Li, Zheng
通讯作者:Li, Zheng
Long noncoding RNA CAR10 promotes lung adenocarcinoma metastasis via miR-203/30/SNAI axis
长非编码RNA CAR10通过miR-203/30/SNAI轴促进肺腺癌转移
DOI:10.1038/s41388-018-0645-x
发表时间:2019-04-18
期刊:ONCOGENE
影响因子:8
作者:Ge, Xiaolu;Li, Gui-yuan;Li, Zheng
通讯作者:Li, Zheng
国内基金
海外基金
